Serum cytokeratin 18 and cytokine elevations suggest A high prevalence of occupational liver disease in highly exposed elastomer/polymer workers

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 10, 2011, Pages 1128-1133

  Cave, Matt ^a,b   Falkner, Keith Cameron ^a   Henry, Latasha ^a   Costello, Brittany ^a   Gregory, Bonnie ^a   McClain, Craig J ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; ACRYLONITRILE; ALCOHOL; CYTOKERATIN 18; CYTOKINE; ELASTOMER; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMER; STYRENE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; HUMAN; LIVER DISEASE; MALE; OBESITY; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE;

EID: 80054037639     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31822cfd68     Document Type: Article

References (42)

1. Cave M, Falkner KC, RayM, et al. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology. 2010;51:474-481.
2. Thiele DL, Eigenbrodt EH, Ware AJ. Cirrhosis after repeated trichloroethylene and 1,1,1-trichloroethane exposure.Gastroenterology. 1982;83:926-929. (Pubitemid 12060534)
3. Zimmerman H. Hepatotoxicity: The Adverse Effects Of Drugs And Other Chemicals On The Liver. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.
4. Creech JL Jr., Johnson MN. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J Occup Med. 1974;16:150-151.
5. Mastrangelo G, Fedeli U, Fadda E, et al. Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: Synergistic effect of occupational exposure with alcohol intake. Environ Health Perspect. 2004;112:1188-1192. (Pubitemid 39157621)
6. Mundt KA, Dell LD,Austin RP, Luippold RS, Noess R, BigelowC. Historical cohort study of 10 109 men in the North American vinyl chloride industry, 1942-72: Update of cancer mortality to 31 December 1995. Occup Environ Med. 2000;57:774-781.
7. Ward E, Boffetta P, Andersen A, et al. Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry. Epidemiology. 2001;12:710-718. (Pubitemid 33134533)
8. Brautbar N, Williams J II. Industrial solvents and liver toxicity: Risk assessment, risk factors and mechanisms. Int J Hyg Environ Health. 2002;205:479-491. (Pubitemid 35265103)
9. Cotrim HP, Andrade ZA, Parana R, Portugal M, Lyra LG, Freitas LA. Nonalcoholic steatohepatitis: A toxic liver disease in industrial workers. Liver. 1999;19:299-304. (Pubitemid 29359094)
10. Cotrim HP, De Freitas LA, Freitas C, et al. Clinical and histopathological features of NASH in workers exposed to chemicals with or without associated metabolic conditions. Liver Int. 2004;24:131-135. (Pubitemid 38584999)
11. Cave M, Deaciuc I, Mendez C, et al. Nonalcoholic fatty liver disease: Predisposing factors and the role of nutrition. J Nutr Biochem. 2007;18:184-195. (Pubitemid 46216810)
12. Gonzalez-Quintela A, Abdulkader I, Campos J, Fernandez-Hernandez L, Lojo S. Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis. Dig Dis Sci. 2009;54:648-653.
13. Syn WK, Choi SS, Diehl AM. Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis. 2009;13:565-580.
14. Feldstein AE,Wieckowska A, Lopez AR, Liu YC, Zein NN,McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study. Hepatology. 2009;50:1072-1078.
15. Nasralla SN, Ghoneim AI, Khalifa AE, Gad MZ, Abdel-Naim AB. Lactoperoxidase catalyzes in vitro activation of acrylonitrile to cyanide. Toxicol Lett. 2009;191:347-352.
16. Filser JG, Faller TH, Bhowmik S, et al. First-pass metabolism of 1,3- butadiene in once-through perfused livers of rats and mice. Chem Biol Interact. 2001;135-136:249-265. (Pubitemid 32530492)
17. Yuan W, Jin H, Chung JK, Zheng J. Evidence for cellular protein covalent binding derived from styrene metabolite. Chem Biol Interact. 2010;186:323-330.
18. Abdelmalek MF, Sanderson SO,Angulo P, et al. Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial. Hepatology. 2009;50:1818-1826.
19. Barve A, Khan R, Marsano L, Ravindra KV, McClain C. Treatment of alcoholic liver disease. Ann Hepatol. 2008;7:5-15. (Pubitemid 351468533)
20. Dannaher CL, Tamburro CH, Yam LT. Occupational carcinogenesis: The Louisville experience with vinyl chloride-associated hepatic angiosarcoma. Am J Med. 1981;70:279-287. (Pubitemid 11146012)
21. Greenberg RA, Tamburro CH. Exposure indices for epidemiological surveillance of carcinogenic agents in an industrial chemical environment. J Occup Med. 1981;23:353-358. (Pubitemid 11098408)
22. Yilmaz Y, Dolar E,Ulukaya E, et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol. 2007;13:837-844. (Pubitemid 46470292)
23. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(suppl 1):S5-S10. (Pubitemid 44309537)
24. Morgan DL, Mahler JF, O'Connor RW, Price HC Jr., Adkins B Jr. Styrene inhalation toxicity studies in mice. I. Hepatotoxicity in B6C3F1 mice. Fundam Appl Toxicol. 1993;20:325-335. (Pubitemid 23138613)
25. Guangwei X, Rongzhu L, Wenrong X, et al. Curcumin pretreatment protects against acute acrylonitrile-induced oxidative damage in rats. Toxicology. 2010;267:140-146.
26. Brodkin CA, Moon JD, Camp J, et al. Serum hepatic biochemical activity in two populations of workers exposed to styrene. Occup Environ Med. 2001;58:95-102. (Pubitemid 32142662)
27. Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2008;47:481-485.
28. Zewdu M, Henry LD, Falkner KC, McClain CJ, Cave M. Serum Cytokeratin 18 and adipocytokines in alcoholic hepatitis versus nonalcoholic steatohepatitis [abstract]. Gastroenterology. 2010;138:S1859.
29. Primavera A, Fustinoni S, Biroccio A, et al. Glutathione transferases and glutathionylated hemoglobin in workers exposed to low doses of 1,3-butadiene. Cancer Epidemiol Biomarkers Prev. 2008;17:3004-3012.
30. Bolt HM,Roos PH, Thier R. The cytochrome P-450 isoenzymeCYP2E1 in the biological processing of industrial chemicals: Consequences for occupational and environmental medicine. Int Arch Occup Environ Health. 2003;76:174-185. (Pubitemid 36740737)
31. Miller MC III, Mohrenweiser HW, Bell DA. Genetic variability in susceptibility and response to toxicants. Toxicol Lett. 2001;120:269-280. (Pubitemid 32375093)
32. Toshimitsu K, Matsuura B, Ohkubo I, et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition. 2007;23:46-52. (Pubitemid 44959764)
33. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675-1685.
34. LinYS, Smith TJ,WypijD,KelseyKT, Sacks FM. Association of the blood/air partition coefficient of 1,3-butadiene with blood lipids and albumin. Environ Health Perspect. 2002;110:165-168. (Pubitemid 34163034)
35. Arteel GE. New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury. J Gastroenterol Hepatol. 2008;23(suppl 1):S54-S59. (Pubitemid 351389031)
36. Devalaraja MN, McClain CJ, Barve S, Vaddi K, Hill DB. Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine. 1999;11:875-881. (Pubitemid 29537537)
37. Abe M, Oshima RG. A single human keratin 18 gene is expressed in diverse epithelial cells of transgenic mice. J Cell Biol. 1990;111:1197-1206.
38. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:11-24. (Pubitemid 13215192)
39. Linder S, Olofsson MH, Herrmann R, Ulukaya E. Utilization of cytokeratinbased biomarkers for pharmacodynamic studies. Expert Rev Mol Diagn. 2010;10:353-359.
40. Chung WY, Sun JS, Park JH, et al. Epithelial apoptosis as a clinical marker in idiopathic interstitial pneumonia. Respir Med. 2010;104:1722-1728.
41. Roth GA, Lebherz-Eichinger D, Ankersmit HJ, et al. Increased total cytokeratin-18 serum and urine levels in chronic kidney disease. Clin Chim Acta. 2011;412:713-717.
42. Lao XQ, Thompson A, McHutchison JG, McCarthy JJ. Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys. J Viral Hepat. 2010;18:571-579.